Carmelo A. Fogliano

Padova, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Distinct neurostructural, cognitive, and neuropsychiatric associations of plasma p-tau217, and Aβ42/40 in Parkinson's disease and aging cohorts.

Distinct neurostructural, cognitive, and neuropsychiatric associations of plasma p-tau217, and Aβ42/40 in Parkinson's disease and aging cohorts.

Journal: Frontiers in aging neuroscience

Published: April 13, 2026

Plasma p-tau217 Versus p-tau181 in Parkinson's Disease: Differential Associations with Alzheimer's Disease-Related Neurostructural Changes and Cognitive Function.

Plasma p-tau217 Versus p-tau181 in Parkinson's Disease: Differential Associations with Alzheimer's Disease-Related Neurostructural Changes and Cognitive Function.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 24, 2026

The challenges with the identification of Parkinson's disease subtypes.

The challenges with the identification of Parkinson's disease subtypes.

Journal: Expert review of neurotherapeutics

Published: December 31, 2025

Infusion therapies for Parkinson's disease: where are we in 2025?

Infusion therapies for Parkinson's disease: where are we in 2025?

Journal: Expert opinion on drug delivery

Published: October 17, 2025

Navigating the therapeutic landscape in advanced Parkinson's disease: a comprehensive review from infusion therapies to stem cells.

Navigating the therapeutic landscape in advanced Parkinson's disease: a comprehensive review from infusion therapies to stem cells.

Journal: Expert opinion on drug delivery

Published: July 30, 2025

Detecting amyloid and tau pathology in Parkinson's disease, 4R-tauopathies and control subjects with plasma pTau217.

Detecting amyloid and tau pathology in Parkinson's disease, 4R-tauopathies and control subjects with plasma pTau217.

Journal: Frontiers in neurology

Published: May 31, 2025

Managing impulse control and related behavioral disorders in Parkinson's disease: where we are in 2025?

Managing impulse control and related behavioral disorders in Parkinson's disease: where we are in 2025?

Journal: Expert review of neurotherapeutics

Published: March 28, 2025

The role of blood-based biomarkers in Parkinsonian disorders, Alzheimer's disease and frontotemporal dementia.

The role of blood-based biomarkers in Parkinsonian disorders, Alzheimer's disease and frontotemporal dementia.

Journal: Journal of the neurological sciences

Published: March 18, 2025

Progranulin Mutation Manifesting as Parkinson Disease: A Case Series from the PADUA-CESNE Cohort.

Progranulin Mutation Manifesting as Parkinson Disease: A Case Series from the PADUA-CESNE Cohort.

Journal: Movement disorders clinical practice

Published: January 02, 2025

Optical coherence tomography reveals retinal structural abnormalities in α-synucleinopathies: insights from the Padua-CESNE cohort.

Optical coherence tomography reveals retinal structural abnormalities in α-synucleinopathies: insights from the Padua-CESNE cohort.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: September 05, 2024

Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes.

Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: November 04, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026